Trial intelligence / Profile preview

Doxycycline vs Comedone Extraction for Moderate Acne Vulgaris

NCT04206631Phase 1Completed

Sponsor
Universitas Indonesia
Start
Apr 2015
Primary completion
Sep 2015
Modality
Small Molecules
01

Overview

Phase 1, randomised, double-blind trial of doxycycline in acne vulgaris, sponsored by Universitas Indonesia. Primary endpoint: Change from Baseline Inflammatory Lesions at 6 weeks. Started Apr 2015; status: completed.

02

Drugs

doxycycline
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on NCT04206631.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04206631.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call